{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:32:32Z","timestamp":1781134352968,"version":"3.54.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240531","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T17:31:56Z","timestamp":1602264716000},"page":"e0240531","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-1648","authenticated-orcid":true,"given":"Kim Sui","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foong Ming","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalijah","family":"Mohd Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-341X","authenticated-orcid":true,"given":"Feisul Idzwan","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainudin","family":"Mohd Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noran Naqiah","family":"Hairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"15","key":"pone.0240531.ref001","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0240531.ref002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"SE Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"pone.0240531.ref003","unstructured":"Ministry of Health Malaysia. Clinical Practice Guidelines for Management of Type 2 Diabetes Mellitus (5th Edition). 2015. Available from: http:\/\/www.acadmed.org.my\/index.cfm?&menuid=67."},{"issue":"9","key":"pone.0240531.ref004","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dc12-1759","article-title":"Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study","volume":"36","author":"MA Stone","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0240531.ref005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/dc15-2439","article-title":"Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study","volume":"39","author":"ND Wong","year":"2016","journal-title":"Diabetes Care"},{"key":"pone.0240531.ref006","unstructured":"Ministry of Health Malaysia. National Diabetes Registry, Report Volume 1, 2009\u20132012. Kuala Lumpur. 2013. Available from: https:\/\/www.moh.gov.my\/moh\/resources\/Penerbitan\/Rujukan\/NCD\/Diabetes\/National_Diabetes_Registry_Report_Vol_1_2009_2012.pdf"},{"issue":"2","key":"pone.0240531.ref007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13300-013-0034-y","article-title":"Adherence to Therapies in Patients with Type 2","volume":"4","author":"L-E Garc\u00eda-P\u00e9rez","year":"2013","journal-title":"Diabetes. Diabetes Ther"},{"issue":"6","key":"pone.0240531.ref008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.diabet.2017.06.003","article-title":"Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus","volume":"43","author":"G Reach","year":"2017","journal-title":"Diabetes Metab"},{"issue":"9","key":"pone.0240531.ref009","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"LS Phillips","year":"2001","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0240531.ref010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.13088","article-title":"Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review","volume":"20","author":"K Khunti","year":"2018","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"7","key":"pone.0240531.ref011","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2337\/dc18-0116","article-title":"Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set","volume":"41","author":"KM Pantalone","year":"2018","journal-title":"Diabetes Care"},{"key":"pone.0240531.ref012","unstructured":"Department of Statistics Malaysia. Demographic statistics first quarter 2020, Malaysia 2020 [cited on 2020 May 28] Available from: https:\/\/www.dosm.gov.my\/v1\/index.php?r=column\/cthemeByCat&cat=430&bul_id=aFYzVjJ3anNyQytHZGxzcUZxTG9Ydz09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09#."},{"key":"pone.0240531.ref013","unstructured":"Institute for Public Health (IPH). National Health and Morbidity Survey 2015 (NHMS 2015) Volume II: Non-Communicable Diseases, Risk Factors & Other Health Problems. 2015. Available from: https:\/\/www.moh.gov.my\/moh\/resources\/nhmsreport2015vol2.pdf"},{"key":"pone.0240531.ref014","unstructured":"United Nations. World Population Ageing 2015\u2014Highlight. 2015. Available from: https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WPA2015_Highlights.pdf"},{"key":"pone.0240531.ref015","volume-title":"Obesity: preventing and managing the global epidemic: Rreport of a WHO consultation (WHO technical report series 894)","author":"World Health Organization","year":"2000"},{"key":"pone.0240531.ref016"},{"issue":"1","key":"pone.0240531.ref017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"N Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"pone.0240531.ref018","volume-title":"Multivariate data analysis: Pearson new international edition","author":"JF Hair","year":"2013"},{"issue":"3","key":"pone.0240531.ref019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"JP Higgins","year":"2008","journal-title":"Clinical Trials"},{"key":"pone.0240531.ref020","article-title":"De-intensification of diabetes treatment in elderly patients with type 2 diabetes mellitus Endocr Pract","author":"DV Pirela","year":"2019"},{"key":"pone.0240531.ref021","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195152968.001.0001","volume-title":"Applied longitudinal data analysis: Modeling change and event occurrence","author":"JD Singer","year":"2003"},{"issue":"Supplement 1","key":"pone.0240531.ref022","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc18-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"pone.0240531.ref023","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2337\/dc15-0187","article-title":"Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists","volume":"38","author":"A Cahn","year":"2015","journal-title":"Diabetes Care"},{"key":"pone.0240531.ref024","unstructured":"Department of Statistics Malaysia. Abridged life tables, Malaysia, 2017\u20132019. 2019. [cited on 2020 July 13] Available from: https:\/\/www.dosm.gov.my\/v1\/index.php?r=column\/pdfPrev&id=YnV4S1FyVnNzUWJlQ3F5NHVMeFY3UT09"},{"key":"pone.0240531.ref025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/dmt.14.45","article-title":"Adherence to treatment guidelines in type 2 diabetes patients failing metformin monotherapy in a real\u2010world setting","volume":"5","author":"K Tunceli","year":"2015","journal-title":"Diabetes Manag"},{"issue":"4","key":"pone.0240531.ref026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/dom.12626","article-title":"Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin","volume":"18","author":"K Khunti","year":"2016","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"9","key":"pone.0240531.ref027","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2337\/dc16-0227","article-title":"Intensification of diabetes therapy and time until A1C goal attainment among patients with newly diagnosed type 2 diabetes who fail metformin monotherapy within a large integrated health system","volume":"39","author":"KM Pantalone","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"pone.0240531.ref028","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1463-1326.2011.01405.x","article-title":"Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy","volume":"13","author":"A Fu","year":"2011","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"6","key":"pone.0240531.ref029","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc08-1911","article-title":"Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD)","volume":"32","author":"LN McEwen","year":"2009","journal-title":"Diabetes Care"},{"issue":"9","key":"pone.0240531.ref030","first-page":"805","article-title":"Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2","volume":"24","author":"L Kallenbach","year":"2018","journal-title":"Diabetes Uncontrolled on Basal Insulin in a Real-World Setting. Endocr Pract"},{"issue":"6","key":"pone.0240531.ref031","doi-asserted-by":"crossref","first-page":"e0199011","DOI":"10.1371\/journal.pone.0199011","article-title":"Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records","volume":"13","author":"RJ Arnold","year":"2018","journal-title":"PLoS One"},{"key":"pone.0240531.ref032","doi-asserted-by":"crossref","first-page":"l5887","DOI":"10.1136\/bmj.l5887","article-title":"Benefits and harms of intensive glycemic control in patients with type 2 diabetes","volume":"367","author":"R Rodriguez-Gutierrez","year":"2019","journal-title":"BMJ"},{"issue":"9733","key":"pone.0240531.ref033","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"The Emerging Risk Factors C","year":"2010","journal-title":"The Lancet"},{"issue":"1","key":"pone.0240531.ref034","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12933-015-0260-x","article-title":"Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes","volume":"14","author":"SK Paul","year":"2015","journal-title":"Cardiovasc Diabetol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T17:32:39Z","timestamp":1602264759000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240531"}},"subtitle":[],"editor":[{"given":"Cheng","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240531","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}